NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Cash Flow
TSX-V:NGMD - TSX Venture Exchange - CA67054F1009 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -8.31M | -9.36M | -5.58M | -7.11M | |||
| Depreciation Amortization | 640.20K | 690.80K | 652.40K | 790.60K | |||
| Change In Working Capital | 2.26M | -734.10K | 603.80K | -235.40K | |||
| Interest Paid | N/A | N/A | 0.00 | 7.50K | |||
| Taxes Paid | N/A | N/A | 3.20K | 3.00K | |||
| Other non cash items | 2.29M | 2.69M | 2.19M | 2.46M | |||
| OPERATING CASH FLOW | -3.12M | -6.71M | -2.13M | -4.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | N/A | -3.00K | -1.00K | -3.60K | |||
| Other Investing Activity | N/A | -50.40K | 0.00 | 5.30K | |||
| INVESTING CASH FLOW | N/A | -53.40K | -1.00K | 1.70K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | 9.98M | -871.30K | -83.90K | 75.00K | |||
| Stock Issued/Repurchased | 870.00K | 7.97M | 672.70K | 5.51M | |||
| Other Financing Activity | N/A | N/A | -75.00K | 0.00 | |||
| FINANCING CASH FLOW | 10.85M | 7.10M | 513.80K | 5.58M | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | -17.00K | |||
| CHANGE IN CASH | 7.68M | 333.00K | -1.62M | 1.47M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -3.12M | -6.71M | -2.13M | -4.10M | |||
| Capital Expenditure | N/A | -3.00K | -1.00K | -3.60K | |||
| FREE CASH FLOW | -3.12M | -6.72M | -2.13M | -4.10M | |||
All data in CAD